Integrated Proteins Q3FY26 Results Show Mixed Performance

Integrated Proteins Limited reported a net loss of ₹1.55 lakh for Q3FY26 compared to profit of ₹6.92 lakh in Q3FY25, with zero revenue from operations during the quarter.

Integrated Proteins Appoints New Company Secretary

Integrated Proteins Limited announces resignation of Ms. Palak Chauhan and appointment of Mr. Girish Kalwani as Company Secretary and Compliance Officer effective December 31, 2025.

Integrated Proteins Limited Approves Quarterly Financial Results, Reports Minimal Profit

Integrated Proteins Limited's Board of Directors approved unaudited financial results for the quarter ended June 30, 2025. The company reported total income of Rs. 4.72 lakh compared to Rs. 4.02 lakh in the same quarter last year, with net profit of Rs. 0.01 lakh versus a loss of Rs. 0.07 lakh in the previous year quarter. The company had no revenue from operations during this quarter, unlike Rs. 2,148.67 lakh in the previous quarter. Total expenses were Rs. 4.71 lakh, primarily consisting of other expenses and employee benefit costs. Earnings per share remained at Rs. 0.00. The company confirmed no deviation in the use of proceeds from its preferential issue that raised Rs. 1,744.88 lakh, with Rs. 667.38 lakh utilized during the quarter for capital expenditure, acquisitions, and general corporate purposes.

Integrated Proteins Limited Appoints New Company Secretary Following Resignation

Integrated Proteins Limited announced leadership changes in its compliance function. Ms. Urvashi Jayeshbhai Gandhi resigned from her position as Company Secretary and Compliance Officer, with her resignation taking effect from the close of business hours on August 1, 2025. The company's Board of Directors approved the appointment of Ms. Palak Chauhan as the new Company Secretary and Compliance Officer, effective August 2, 2025. Ms. Chauhan is an Associate Member of the Institute of Company Secretaries of India with a background in corporate law, governance, and compliance. The changes were approved during a Board meeting held on August 1, 2025.

Integrated Proteins Limited Schedules Board Meeting to Consider Warrant Conversion

Integrated Proteins Limited has scheduled a Board of Directors meeting on August 7, 2025 to consider the conversion of convertible equity warrants into equity shares and their allotment to non-promoter warrant holders. The company notified BSE Limited about the board meeting agenda, which also includes transacting other business with the Chairman's permission.